Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts

John R Harrison1, Henning W Woitge, Barbara E Kream

  • 1Department of Orthodontics, School of Dental Medicine, University of Connecticut Health Center, Farmington, USA.

Endocrine
|May 17, 2002
PubMed

Insights

Glucocorticoids can both decrease and increase bone mass. This review explores their opposing effects on bone formation and proposes mouse models to study endogenous glucocorticoid actions.

Area of Science:

  • Bone biology
  • Endocrinology
  • Pharmacology

Background:

  • Glucocorticoids influence bone metabolism, with high levels typically reducing bone mass.
  • In vitro studies show glucocorticoids can also stimulate osteoblast differentiation, but in vivo relevance is unclear.

Purpose of the Study:

  • To review the dual effects of glucocorticoids on bone formation.
  • To propose genetic mouse models for investigating endogenous glucocorticoid roles in bone.

Main Methods:

  • Review of existing in vivo and in vitro experimental models.
  • Proposal of genetic loss-of-function mouse models targeting glucocorticoid signaling in osteoblasts.

Main Results:

  • Glucocorticoids exhibit opposing effects on bone formation, depending on experimental conditions.
  • Existing models provide insights but do not fully elucidate endogenous glucocorticoid roles.

Conclusions:

  • Further research using targeted genetic models is needed to clarify the precise role of endogenous glucocorticoids in bone homeostasis.
  • Understanding these pathways is crucial for developing therapeutic strategies for bone diseases.